Browse All

Current Filters

CLEAR FILTER x

TITLE

Treatment with Eptinezumab Reduces Brain Fog and Increases the Number of Good Days Per Month in Patients with Chronic Migraine in a Real-world Setting

Treatment with Zavegepant Offers Improvements in Pain Severity Over 48-hours When Compared with Placebo—Post Hoc Results from a Randomized Placebo-controlled Trial (BHV3500-301)